- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Blacktown, New South Wales, Australia
- GSK Investigational Site Kanwal, New South Wales, Australia
- GSK Investigational Site Gold Coast, Queensland, Australia
- GSK Investigational Site Sherwood, Queensland, Australia
Clinical trial condition
Meningococcal Infections
Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.
217 public trials
6 recruiting studies
Meningococcal Infections trial results
Completed
Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)
NCT02569632
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +3 more
- Locations
-
- UCSF Benioff Children's Hospital Oakland Oakland, California, United States
- University of Massachusetts Medical School Worcester, Massachusetts, United States
NCT01144663
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Haabneeme, Estonia
- GSK Investigational Site Tallinn, Estonia
- GSK Investigational Site Tallinn, Estonia
- GSK Investigational Site Tallinn, Estonia
NCT03125616
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Female Urogenital Diseases and Pregnancy Complications, +12 more
- Locations
-
- St Georges University Hospital NHS Foundation Trust Tooting, London, United Kingdom
NCT01266993
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Draguignan, France
- GSK Investigational Site Le Havre, France
- GSK Investigational Site Lingolsheim, France
- GSK Investigational Site Miribel, France
Completed
Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects
NCT00514904
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Goā, India
- GSK Investigational Site Indore, India
- GSK Investigational Site New Delhi, India
- GSK Investigational Site Vellore, India
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- Espoo Vaccine Research Clinic Espoo, Finland
- Helsinki South Vaccine Research Clinic Helsinki, Finland
- Oulu Vaccine Research Clinic Oulu, Finland
- Pori Vaccine Research Clinic Pori, Finland
Completed
Hepatitis B Vaccination in Infants
NCT01896596
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +29 more
- Locations
-
- St George's Vaccien Institute London, United Kingdom
NCT00197808
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
- Locations
-
- Hertfordshire Primary Care Trusts Welwyn Garden City, Hertfordshire, United Kingdom
- Gloucestershire Primary Care Trusts Gloucester, United Kingdom
NCT02640677
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Wilmington, North Carolina, United States